Anand Swaminath

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiotherapie

Stereotactic Body Radiotherapie Boost Following Urgent 3D Conformal Radiotherapie for Gemetastaseerd Epidural Spinal Cord Compression: A Phase 1 Haalbaarheid Studie

Kwaliteit van leven of Stereotactic Versus Hypogefractioneerde Radiotherapie for Inoperable Stage I Non-Small Cell Longkanker: Resultaten From the LUSTRE Trial

Dosimetric Uitkomsten of Stereotactic Body Radiotherapie to Ultracentral Lung Tumors: Lessons From the SUNSET Trial

Werkzaamheid of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analyse From the International Radiosurgery Oncology Consortium of the Kidney

SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial

Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a ...

Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Ger...

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 R...

Vijfjaars SABR bij primair niercelcarcinoom: internationale analyse

Metformine plus chemoradiatie bij lokaal gevorderd NSCLC: OCOG-ALMERA fase II

SABR versus standaard palliatieve RT bij oligometastasen: SABR-COMET fase II